GSK To Generics: Hands Off Paxil Patents
GlaxoSmithKline escalated its war over blockbuster antidepressant Paxil on another front Monday, filing suit against Mylan Laboratories Inc. in a New Jersey district court over the generics maker's alleged patent infringement....To view the full article, register now.
Already a subscriber? Click here to view full article